Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1996
05/14/1996US5516631 Method of inhibiting replication of hyperproliferative cells
05/14/1996US5516629 Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
05/14/1996US5516525 Vitamin D derivative feed compositions and methods of use
05/14/1996US5516515 Separation of alpha interferon receptor proteins and antibodies therefor
05/09/1996WO1996013616A1 Peptides for detection of hepatitis c antibodies
05/09/1996WO1996013614A1 Bcl-x/bcl-2 associated cell death regulator
05/09/1996WO1996013610A2 Methods and reagents for the identification and regulation of senescence-related genes
05/09/1996WO1996013607A1 Compositions for the detection of proteases in biological samples and methods of use thereof
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013598A2 Hybrid adenovirus-aav virus and method of use thereof
05/09/1996WO1996013594A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof
05/09/1996WO1996013593A2 Soluble single chain t cell receptors
05/09/1996WO1996013592A2 Protein kinase npk-110
05/09/1996WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996WO1996013587A1 Chemokine-like proteins and methods of use
05/09/1996WO1996013586A2 Histiocyte-secreted factor (hsf)
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013584A1 Chimeric receptors for the generation of selectively-activatable th-independent cytotoxic t cells
05/09/1996WO1996013583A2 Targeted hetero-association of recombinant proteins to multi-functional complexes
05/09/1996WO1996013581A1 Growth inhibitory peptide and methods of using same
05/09/1996WO1996013575A1 Recombinant feline herpes virus
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/09/1996WO1996013514A1 Tcl-1 gene and protein and related methods and compositions
05/09/1996WO1996013513A1 Alzheimer's peptide
05/09/1996WO1996013506A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996WO1996013290A1 Device for aerosolized delivery of peptide drugs
05/09/1996WO1996013286A2 Modulation of cell proliferation and wound healing
05/09/1996WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
05/09/1996WO1996013276A1 Ocular gene therapy
05/09/1996WO1996013275A1 Methods and products for enhancing immune responses
05/09/1996WO1996013274A1 Process for production of inhibited forms of activated blood factors
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013272A1 Aza cyclohexapeptide compounds
05/09/1996WO1996013269A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996WO1996013257A1 Use of receptor potentiators
05/09/1996WO1996013256A1 Drugs containing nitric oxide synthase inhibitors for treating immunodeficiency diseases
05/09/1996WO1996013250A1 Compositions for increased bioavailability of orally delivered therapeutic agents
05/09/1996WO1996013247A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996WO1996013226A1 Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method
05/09/1996WO1996013161A1 Creating an aerosolized formulation of insulin
05/09/1996WO1996013160A1 Use of urokinase-type plasminogen activators to inhibit hiv infectivity
05/09/1996WO1996010034A3 Thiol-free inhibitors of farnesyl-protein transferase
05/09/1996WO1996007734A3 Recombinant adenovirus comprising a chimeric penton base protein
05/09/1996DE19540669A1 Non-parenteral interferon compsn.
05/09/1996DE19539860A1 Oral cyclosporin formulations
05/09/1996CA2513441A1 Pharmaceutical compositions
05/09/1996CA2204183A1 Chimeric receptors for the generation of selectively-activatable th-independent cytotoxic t cells
05/09/1996CA2203910A1 Novel protein kinase (npk-110)
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203807A1 Process for production of inhibited forms of activated blood factors
05/09/1996CA2203767A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996CA2203641A1 Bcl-x/bcl-2 associated cell death regulator
05/09/1996CA2203374A1 Ocular gene therapy
05/09/1996CA2203257A1 Device for aerosolized delivery of peptide drugs
05/09/1996CA2203236A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof
05/09/1996CA2202920A1 Aza cyclohexapeptide compounds
05/09/1996CA2202889A1 Chemokine-like proteins and methods of use
05/09/1996CA2202881A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996CA2201703A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996CA2200886A1 Use of ner receptors potentiators
05/09/1996CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/08/1996EP0710723A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
05/08/1996EP0710722A1 Genetic mechanisms of tumor suppression
05/08/1996EP0710720A1 Method for the production of monoclonal antibodies utilizing a germfree animal
05/08/1996EP0710719A1 Generation of xenogeneic antibodies
05/08/1996EP0710669A1 Novel protein having avidity with heparin-binding growth factor
05/08/1996EP0710295A1 Htlv-ii nra? compositions and assays for detecting htlv infection
05/08/1996EP0710287A1 Homologously recombinant slow growing mycobacteria and uses therefor
05/08/1996EP0710286A1 Methods and dna expression systems for over-expression of proteins in host cells
05/08/1996EP0710285A1 Analogues of an anti-thrombin polypeptide and process for their preparation
05/08/1996EP0710281A1 A method of producing a protein disulfide redox agent
05/08/1996EP0710251A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
05/08/1996EP0710249A1 Selective amylin antagonist peptides and uses therefor
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/08/1996EP0710247A1 Process for manufacture of 1-deamino-8-d-arginine vasopressin
05/08/1996EP0710244A1 Immunoreactive reagents employing monoamine oxidase
05/08/1996EP0710243A1 Improved synthesis of cyclic peptides
05/08/1996EP0710123A1 Adenovirus vectors for gene therapy sponsorship
05/08/1996EP0710122A1 Stabilized pharmaceutical peptide compositions
05/08/1996EP0710121A1 Method for treating multiple sclerosis
05/08/1996EP0710115A1 Method for administering hemoglobin
05/08/1996EP0710114A1 A coagulation factor viii formulation
05/08/1996EP0710104A1 Pharmaceutical compositions for hardly soluble active substances
05/08/1996EP0710103A1 Pharmaceutical compositions for hardly soluble active substances
05/08/1996EP0710102A1 Stabilization of aerosolized proteins
05/08/1996EP0688168A4 Method of treating immature birds with il-2
05/08/1996EP0576669A4 Novel methods and compositions for treatment of angiogenic diseases
05/08/1996EP0517778B1 Vasoactive vasotocin derivatives
05/08/1996EP0424473B1 Methods for identification of bacteria
05/08/1996EP0423198B1 Antibodies specific towards hiv 1 gp 48
05/08/1996CN1122108A Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract
05/08/1996CN1121832A Anticancer drug
05/07/1996US5514788 Oligonucleotide modulation of cell adhesion
1 ... 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 ... 3163